Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Glass House Brands Inc. (GLAS)

BGM Group Ltd. and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. Glass House Brands Inc. is the larger, with a market value of $172.7M against $125.7M — 1.4× the size. Glass House Brands Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs −36.2%) and the higher return on invested capital (0.00% vs −23.4%). Across the 14 metrics below, BGM Group Ltd. leads on 11 and Glass House Brands Inc. on 3.

Valuation

Metric BGM GLAS Drug Manufacturers Specialty & Generic median
P/E 148.17 n/m 20.55
P/S n/m 1.14 2.08
P/B n/m 2.79 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales (0.09) 1.35 2.87
Earnings yield 0.67% (33.33%) (15.94%)
Free cash flow yield 0.00% (18.18%) 0.00%

Profitability

Metric BGM GLAS Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 31.97% 53.51%
Operating margin 0.00% (23.18%) 0.00%
Net margin 1.96% (36.19%) (2.45%)
Free cash flow margin 0.00% (20.78%) 0.00%
Return on equity 0.00% (74.02%) (0.80%)
Return on assets 0.00% (19.78%) (1.67%)
Return on invested capital 0.00% (23.36%) 0.00%

Growth

Metric BGM GLAS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (15.38%) 5.22%
EPS growth (last fiscal year) 10.00% (161.90%) 42.91%
Revenue growth, 5-year CAGR (5.39%) — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BGM GLAS Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.77 0.04
Current ratio 1.25 1.33 2.41
Net debt to EBITDA 0.97 (64.84) 1.01

Dividend

Metric BGM GLAS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BGM GLAS Drug Manufacturers Specialty & Generic median
Market cap 125.72m 172.67m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack